12 results
8-K
CYT
Cyteir Therapeutics Inc
31 May 23
Departure of Directors or Certain Officers
4:27pm
Therapeutics, Inc. (the “Company”) and the Nominating and Corporate Governance Committee of the Board of Directors, to be effective immediately. Dr
S-3
EX-25
CYT
Cyteir Therapeutics Inc
8 Aug 22
Shelf registration
5:29pm
for its corporate governance procedures, to the extent not inconsistent with Federal banking statutes and regulations or bank safety and soundness
DEF 14A
CYT
Cyteir Therapeutics Inc
29 Apr 22
Definitive proxy
1:49pm
AND CORPORATE GOVERNANCE
EXECUTIVE OFFICER AND DIRECTOR COMPENSATION
AUDIT COMMITTEE REPORT
CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
PROPOSAL NO. 1 … that are exercisable within 60 days of March 31, 2022.
MANAGEMENT AND CORPORATE GOVERNANCE
In accordance with our amended and restated certificate
10-K
2021 FY
CYT
Cyteir Therapeutics Inc
16 Mar 22
Annual report
4:08pm
management is required to devote substantial time to new compliance initiatives and corporate governance practices.
As a public company, and particularly … and maintenance of effective disclosure and financial controls and corporate governance practices. We are continuing to hire additional accounting, finance
424B4
5ewhs4a vqehzauhl
21 Jun 21
Prospectus supplement with pricing info
6:13am
S-1/A
hf1qcbn
4 Jun 21
IPO registration (amended)
4:32pm
S-1
s12hq
28 May 21
IPO registration
4:01pm
DRS/A
kxr1x9lpzysb0dvsreh
14 May 21
Draft registration statement (amended)
12:00am
DRS/A
crgzna55tld sw6bhaz
30 Apr 21
Draft registration statement (amended)
12:00am
DRS
lgvxrvb 4s270l6
26 Mar 21
Draft registration statement
12:00am
- Prev
- 1
- Next